Sign in
4

Changes in Ownership

Gossamer Bio, Inc. Filed Acc 0001857256-26-000004

Options or other derivatives

  • EVP, Regulatory Affairs acquired 1,992,203 shares (grant or award)
  • EVP, Regulatory Affairs returned 1,992,203 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Peterson Caryn · EVP, Regulatory Affairs

Table II: Derivative

24 lines
Date Transaction Shares Owned after D/I
2026-03-19 Returned to the company : show line 1 in the form Stock Option (Right to Buy) −506,250 0 D
2026-03-19 Returned to the company : show line 2 in the form Stock Option (Right to Buy) −440,000 0 D
2026-03-19 Returned to the company : show line 3 in the form Stock Option (Right to Buy) −375,000 0 D
2026-03-19 Returned to the company : show line 4 in the form Stock Option (Right to Buy) −125,000 0 D
2026-03-19 Returned to the company : show line 5 in the form Stock Option (Right to Buy) −157,500 0 D
2026-03-19 Returned to the company : show line 6 in the form Stock Option (Right to Buy) −157,500 0 D
2026-03-19 Returned to the company : show line 7 in the form Stock Option (Right to Buy) −126,667 0 D
2026-03-19 Returned to the company : show line 8 in the form Stock Option (Right to Buy) −21,167 0 D
Loading xslF345X06/wk-form4_1774038052.xml…